Richard Close
Stock Analyst at Canaccord Genuity
(1.15)
# 3,655
Out of 5,182 analysts
154
Total ratings
29.51%
Success rate
-14%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $33 → $22 | $9.06 | +142.83% | 13 | Mar 31, 2026 | |
| DCGO DocGo | Maintains: Hold | $1.5 → $1 | $0.53 | +88.68% | 9 | Mar 25, 2026 | |
| CLOV Clover Health Investments | Maintains: Buy | $3.7 → $3.2 | $2.15 | +48.84% | 7 | Mar 20, 2026 | |
| HCAT Health Catalyst | Maintains: Buy | $5 → $2 | $1.23 | +62.60% | 10 | Mar 13, 2026 | |
| PGNY Progyny | Maintains: Hold | $26 → $19 | $17.39 | +9.26% | 10 | Mar 11, 2026 | |
| TALK Talkspace | Downgrades: Hold | n/a | $5.17 | - | 3 | Mar 9, 2026 | |
| OMDA Omada Health | Maintains: Buy | $28 → $22 | $13.12 | +67.68% | 3 | Mar 6, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $34 → $35 | $23.44 | +49.32% | 10 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: Buy | $12 → $10 | $5.54 | +80.51% | 17 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.55 | +52.67% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $30 | $24.68 | +21.56% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $53 | $41.47 | +27.80% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $34 | $23.90 | +42.26% | 14 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 | $21.04 | +33.08% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $9 | $2.88 | +212.50% | 13 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $12.65 | +18.58% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $134.37 | -9.95% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $28.34 | -15.31% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $69.42 | +36.85% | 9 | Apr 22, 2021 |
Phreesia
Mar 31, 2026
Maintains: Buy
Price Target: $33 → $22
Current: $9.06
Upside: +142.83%
DocGo
Mar 25, 2026
Maintains: Hold
Price Target: $1.5 → $1
Current: $0.53
Upside: +88.68%
Clover Health Investments
Mar 20, 2026
Maintains: Buy
Price Target: $3.7 → $3.2
Current: $2.15
Upside: +48.84%
Health Catalyst
Mar 13, 2026
Maintains: Buy
Price Target: $5 → $2
Current: $1.23
Upside: +62.60%
Progyny
Mar 11, 2026
Maintains: Hold
Price Target: $26 → $19
Current: $17.39
Upside: +9.26%
Talkspace
Mar 9, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.17
Upside: -
Omada Health
Mar 6, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $13.12
Upside: +67.68%
Privia Health Group
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $35
Current: $23.44
Upside: +49.32%
Teladoc Health
Feb 26, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $5.54
Upside: +80.51%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $6.55
Upside: +52.67%
Feb 18, 2026
Maintains: Buy
Price Target: $54 → $30
Current: $24.68
Upside: +21.56%
Feb 11, 2026
Maintains: Buy
Price Target: $65 → $53
Current: $41.47
Upside: +27.80%
Feb 9, 2026
Upgrades: Buy
Price Target: $48 → $34
Current: $23.90
Upside: +42.26%
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $21.04
Upside: +33.08%
Nov 14, 2025
Maintains: Buy
Price Target: $16 → $9
Current: $2.88
Upside: +212.50%
Nov 6, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $12.65
Upside: +18.58%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $134.37
Upside: -9.95%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $28.34
Upside: -15.31%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $69.42
Upside: +36.85%